Stockreport

Treos Bio to Present New Clinical Data on Off-the-Shelf Peptide Immunotherapy for Colorectal Cancer at 2024 ASCO Annual Meeting [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF to develop precision peptide immunotherapies, said investigators will present new results from a phase 2 trial of the company's lead product candidate PolyPEPI1018 in co [Read more]